FDA-approved Abl/EGFR/PDGFR kinase inhibitors show potent efficacy against pandemic and seasonal influenza A virus infections of human lung explants

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Robert Meineke et al.

Journal title: iScience

Journal publisher: Elsevier

Published year: 2023

DOI identifier: 10.1016/j.isci.2023.106309

ISSN: 2589-0042